Caffeic acid phenethyl ester suppresses eotaxin secretion and nuclear p-STAT6 in human lung fibroblast cells

Journal of Microbiology, Immunology and Infection

Volumn 44, Issue 6, 2011, Pages 435-441

  Lin, Yu Ting ^a   Hsu, Jeng Yuan ^a,b   Chen, Ciao Jin ^a   Chu, Jao Jia ^a   Fu, Lin Shien ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Caffeic acid phenethyl ester; Eotaxin; Human lung fibroblast cell; P STAT6; STAT6

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; DNA BINDING PROTEIN; EOTAXIN; INTERLEUKIN 4; NUCLEAR PROTEIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC DISEASE; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

CAFFEIC ACIDS; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CHEMOKINE CCL11; DNA; FIBROBLASTS; HUMANS; INTERLEUKIN-4; PHENYLETHYL ALCOHOL; PHOSPHORYLATION; STAT6 TRANSCRIPTION FACTOR; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83155172515     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.04.008     Document Type: Article

References (31)

1. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. N Engl J Med 1990, 323:1033-1039.
2. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326:298-304.
3. Maddox L., Schwartz D.A. The pathophysiology of asthma. Annu Rev Med 2002, 53:477-498.
4. Gleich G.J. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990, 85:422-436.
5. Gundel R.H., Letts L.G., Gleich G.J. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991, 87:1470-1473.
6. Tang M.L.K., Wilson J.W., Stewart A.G., Royce S.G. Airway remodelling in asthma: Current understanding and implications for future therapies. Pharmacol Ther 2006, 112:474-488.
7. Mochizuki M., Bartels J., Mallet A.I., Christophers E., Schroder J.M. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998, 160:60-68.
8. Stellato C., Matsukura S., Fal A., White J., Beck L.A., Proud D., et al. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 1999, 163:5624-5632.
9. Odaka M., Matsukura S., Kuga H., Kokubu F., Kasama T., Kurokawa M., et al. Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smooth muscle cells. Int Arch Allergy Immunol 2007, 143(Suppl. 1):84-88.
10. Jose P.J., Griffiths-Johnson D.A., Collins P.D., Walsh D.T., Moqbel R., Totty N.F., et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994, 179:881-887.
11. Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T., Celestin J., Leder P., Luster A.D. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996, 2:449-456.
12. Conroy D.M., Williams T.J. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2001, 2:150-156.
13. Pease J.E., Williams T.J. Eotaxin and asthma. Curr Opin Pharmacol 2001, 1:248-253.
14. Teran L.M., Mochizuki M., Bartels J., Valencia E.L., Nakajima T., Hirai K., et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999, 20:777-786.
15. Sato E., Nelson D.K., Koyama S., Hoyt J.C., Robbins R.A. Inflammatory cytokines modulate eotaxin release by human lung fibroblast cell line. Exp Lung Res 2001, 27:173-183.
16. Rokudai A., Terui Y., Kuniyoshi R., Mishima Y., Aizu-Yokota E., Sonoda Y., et al. Differential regulation of eotaxin-1/CCL11 and eotaxin-3/CCL26 production by the TNF-alpha and IL-4 stimulated human lung fibroblast. Biol Pharm Bull 2006, 29:1102-1109.
17. Matsukura S., Stellato C., Plitt J.R., Bickel C., Miura K., Georas S.N., et al. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol 1999, 163:6876-6883.
18. Atasoy U., Curry S.L., Lopez de Silanes I., Shyu A.B., Casolaro V., Gorospe M., et al. Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR. J Immunol 2003, 171:4369-4378.
19. Hoeck J., Woisetschlager M. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. J Immunol 2001, 166:4507-4515.
20. Burdock G.A. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol 1998, 36:347-363.
21. Jung W.K., Lee D.Y., Choi Y.H., Yea S.S., Choi I., Park S.G., et al. Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma. Life Sci 2008, 82:797-805.
22. Liao Y.R., Hsu J.Y., Chu J.J., Fu L.S. Caffeic acid phenethyl ester suppresses the induction of eotaxin in human lung fibroblast cells. J Asthma 2010, 47:233-237.
23. Shih M.Y., Hsu J.Y., Weng Y.S., Fu L.S. Influence of cetirizine and levocetirizine on two cytokines secretion in human airway epithelial cells. Allergy Asthma Proc 2008, 29:480-485.
24. Ohmori Y., Smith M.F., Hamilton T.A. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 1996, 157:2058-2065.
25. Kuperman D.A., Schleimer R.P. Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr Mol Med 2008, 8:384-392.
26. Zhu J.F., Guo L.Y., Watson C.J., Hu-Li J., Paul W.E. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol 2001, 166:7276-7281.
27. Hebenstreit D., Wirnsberger G., Horejs-Hoeck J., Duschl A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 2006, 17:173-188.
28. Natarajan K., Singh S., Burke T.R., Grunberger D., Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 1996, 93:9090-9095.
29. Fitzpatrick L.R., Wang J., Le T. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J Pharmacol Exp Ther 2001, 299:915-920.
30. Thieu V.T., Nguyen E.T., McCarthy B.P., Bruns H.A., Kapur R., Chang C.H., et al. IL-4-stimulated NF-kappaB activity is required for Stat6 DNA binding. J Leukoc Biol 2007, 82:370-379.
31. Chiba Y., Todoroki M., Nishida Y., Tanabe M., Misawa M. A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice. Am J Respir Cell Mol Biol 2009, 41:516-524.